In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

OBJECTIVES: Colistin is still a “last-resort” antibiotic used to manage human infections due to multidrug-resistant (MDR) Klebsiella pneumoniae. However, colistin-resistant K. pneumoniae (CR-Kp) isolates emerged a decade ago and had a worldwide distribution. The purpose of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wei, Luo, Qixia, Shi, Qingyi, Huang, Chen, Yu, Xiao, Niu, Tianshui, Zhou, Kai, Zhang, Jiajie, Xiao, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926077/
https://www.ncbi.nlm.nih.gov/pubmed/29731646
http://dx.doi.org/10.2147/IDR.S160474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926077/
https://www.ncbi.nlm.nih.gov/pubmed/29731646
http://dx.doi.org/10.2147/IDR.S160474

Ejemplares similares